Galderma and PMCPA Tangle in a Toxic Tussle | Pharmaguy's Insights Into Drug Industry News |

Following a spat over a complaint, a U.K. industry group that enforces a voluntary marketing code has removed a drug from the list of companies that agreed to its oversight.

The unusual development comes after the Prescription Medicines Code of Practice Authority publicly reprimanded Galderma, a specialty drug maker that sells dermatologic products, for breaching the code and refusing to submit to an audit of its practices. The PMCPA administers the code for the Association of the British Pharmaceutical Industry.

The complaint that set this in motion was filed by an anonymous registered nurse, who objected to arrangements for an educational meeting that was sponsored by the drug maker. The nurse was “disgusted” that, while there was no charge to attend the session, attendees were required to prove they first purchased two boxes of Galderma dermal fillers from a pharmacy, according to PMCPA.